Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CNSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CNSP

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Cns Pharmaceuticals Inc

CNSP
Current price
0.80 USD -0.04 USD (-4.76%)
Last closed 0.90 USD
ISIN US18978H1023
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 4 893 904 USD
Yield for 12 month -98.49 %
1Y
3Y
5Y
10Y
15Y
CNSP
21.11.2021 - 28.11.2021

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas. Address: 2100 West Loop South, Houston, TX, United States, 77027

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.00 USD

P/E Ratio

Dividend Yield

Financials CNSP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CNSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

+3 140 USD

Last Quarter

Current Year

-3 306 USD

Last Year

-4 134 USD

Current Quarter

+1 570 USD

Last Quarter

EBITDA -15 691 161 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -127.31 %
PEG Ratio
Return On Equity TTM -477.53 %
Wall Street Target Price 7.00 USD
Revenue TTM
Book Value 3.73 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -924.60 USD
Diluted Eps TTM -924.60 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation CNSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.40
Price Book MRQ 0.44

Technical Indicators CNSP

For 52 Weeks

0.73 USD 62.00 USD
50 Day MA 1.01 USD
Shares Short Prior Month 461 109
200 Day MA 3.66 USD
Short Ratio 0.11
Shares Short 399 235
Short Percent 8.44 %